MEDINCELL held its mixed meeting on September 8, 2022 at 6 pm.
The meeting approved the annual financial statements and consolidated financial statements for the fiscal year ending March 31, 2022. Concerning the governance part, it decided to appoint Tone Kvale as a member of the Supervisory Board in replacement of Crédit Mutuel Innovation, for the remaining term of Crédit Mutuel Innovation’s mandate, expiring at the end of the shareholders’ meeting called to approve the financial statements for the fiscal year ending March 31, 2023. Finally, the Board approved several delegations of authority to increase the company’s share capital.
Finally, the shareholders approved numerous resolutions with more than 80%.
Resolution number 5, which concerned the report of the auditors, was approved by 75%. Then the resolutions number 11 and 14 were voted with 79%, one on the remuneration policy applicable to the Chairman of the Board of Directors and the other on the remuneration policy applicable to the members of the Supervisory Board.
Concerning the extraordinary part, resolution number 16 was approved by 74% and concerned the authorization to be given to the Board of Directors to reduce the share capital by cancelling treasury shares.
Secondly, resolution number 17 was approved by 79% and concerned a delegation of powers to operate on the share capital. Furthermore, number 24 was voted at 76% and concerned a delegation of powers to the Board of Directors to issue shares and securities involving an increase in share capital as remuneration for contributions in kind.
Also number 31 voted at 5% it concerned a delegation of powers to operate on the share capital. Finally, number 32 voted at 2%, which concerned the examination of the situation of the Company and the decision to be taken in application of article L. 225-248 of the Commercial Code concerning its early dissolution